The immuno-oncology firm said it is eligible to receive an additional $700 million in future milestone payments as well as tiered royalties on global net sales.
Shares rose 13% in premarket trading.
Price: 44.04, Change: +0.34, Percent Change: +13.08
|--BTIG Initiates Eve at Neutral|
|Insider Buy: Greenwich Lifesciences|
|BofA Securities Reinstates Darden Restaurants at Buy...|
|Loop Capital Adjusts FedEx's Price Target to $339 Fr...|
|Insider Sell: Velodyne Lidar|